Medpace (MEDP)
(Delayed Data from NSDQ)
$388.35 USD
-11.86 (-2.96%)
Updated Apr 30, 2024 04:00 PM ET
After-Market: $388.35 0.00 (0.00%) 4:46 PM ET
1-Strong Buy of 5 1
D Value A Growth D Momentum C VGM
Brokerage Reports
0 items in cart
Medpace Holdings, Inc. [MEDP]
Reports for Purchase
Showing records 1 - 20 ( 124 total )
Company: Medpace Holdings, Inc.
Industry: Medical Services
Optimized Entry and Exit Levels for MEDP 112223
Provider: Stock Traders Daily
Analyst: Research Department
Company: Medpace Holdings, Inc.
Industry: Medical Services
Company: Medpace Holdings, Inc.
Industry: Medical Services
Company: Medpace Holdings, Inc.
Industry: Medical Services
Company: Medpace Holdings, Inc.
Industry: Medical Services
Life Science Tools & Services - Alert: MEDP Results and VC Funding Show CRO Debate Continuing and BioProcess Growth Visible
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Medpace Holdings, Inc.
Industry: Medical Services
Early Stage Funding Concerns Signaled Again
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Medpace Holdings, Inc.
Industry: Medical Services
Company: Medpace Holdings, Inc.
Industry: Medical Services
Company: Medpace Holdings, Inc.
Industry: Medical Services
Life Science, Bioproduction, CROs: Positive Data Points for 2023
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Medpace Holdings, Inc.
Industry: Medical Services
Transferring Coverage of 5 Companies, Suspending Coverage of 16 Companies, Terminating Coverage of 1 Company
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Medpace Holdings, Inc.
Industry: Medical Services
Company: Medpace Holdings, Inc.
Industry: Medical Services
Company: Medpace Holdings, Inc.
Industry: Medical Services
Company: Medpace Holdings, Inc.
Industry: Medical Services
Company: Medpace Holdings, Inc.
Industry: Medical Services
Growth Accelerating in 2021 and 2022 (Initial 3Q21 Takeaways)
Provider: KEYBANC CAPITAL MARKETS
Analyst: HOOKER D
Company: Medpace Holdings, Inc.
Industry: Medical Services
Company: Medpace Holdings, Inc.
Industry: Medical Services
Company: Medpace Holdings, Inc.
Industry: Medical Services
Company: Medpace Holdings, Inc.
Industry: Medical Services
In-Line 2Q21 Results Despite Biotech Concerns (Pre Conference Call)
Provider: KEYBANC CAPITAL MARKETS
Analyst: HOOKER D